Recombinant Human PI15 Protein，His

PI15, or Proteinase Inhibitor 15, is a serine protease inhibitor predominantly expressed in various tissues, including the skin and the digestive system. It plays a critical role in regulating proteolytic activity, which is essential for maintaining homeostasis and modulating inflammatory responses. Research has shown that PI15 is involved in protecting cells against proteolysis, which can lead to tissue damage and chronic inflammation if left unchecked. Additionally, PI15 has garnered interest due to its potential implications in metabolic disorders and cancer, as it may influence tumor progression by modulating the extracellular matrix and impacting cell migration. Understanding the structure and function of PI15 at the molecular level is crucial for elucidating its role in physiological and pathological processes. Recent advancements in biotechnology have facilitated the recombinant production of PI15, providing a valuable tool for studying its mechanism of action and exploring its therapeutic potential. These studies aim to harness PI15 as a biomarker for disease diagnosis and as a target for novel therapeutic strategies, highlighting its significance in health and disease. The ongoing research into PI15 not only enhances our understanding of protease inhibition but also opens new avenues for the development of innovative treatments for various conditions associated with protease dysregulation.